Cargando…
KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare endocrine neoplasia with poor prognosis. Emerging evidence suggests that kinesin family member 11 (KIF11) protein is overexpressed in several tumors and associated with the onset and progression of certain types of cancer; however, its biological...
Autores principales: | Zhou, Yan, Chen, Xiang, Li, Bingsheng, Li, Yang, Zhang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170266/ https://www.ncbi.nlm.nih.gov/pubmed/37181234 http://dx.doi.org/10.21037/tau-22-706 |
Ejemplares similares
-
Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer
por: Daigo, Kayo, et al.
Publicado: (2017) -
KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2021) -
Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019) -
KIF11: A potential prognostic biomarker for predicting bone metastasis-free survival of prostate cancer
por: Wang, Haoyuan, et al.
Publicado: (2022) -
Pan-Cancer Analysis Reveals CENPI as a Potential Biomarker and Therapeutic Target in Adrenocortical Carcinoma
por: Wu, Feima, et al.
Publicado: (2023)